These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The intrauterine device: rethinking old paradigms. Morgan KW J Midwifery Womens Health; 2006; 51(6):464-70. PubMed ID: 17081937 [TBL] [Abstract][Full Text] [Related]
24. Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices. Ylikorkala O; Kauppila A; Siljander M Lancet; 1978 Aug; 2(8086):393-5. PubMed ID: 79760 [TBL] [Abstract][Full Text] [Related]
25. [Intrauterine device-induced menorrhagia and endometrial content of prostacyclins]. Zhang JY; Luo LL Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):167-8, 190. PubMed ID: 1395902 [TBL] [Abstract][Full Text] [Related]
26. Aminocaproic acid for bleeding associated with intrauterine devices? Drug Ther Bull; 1972 Sep; 10(20):78-80. PubMed ID: 4664710 [No Abstract] [Full Text] [Related]
27. [Intrauterine contraception with bioactive devices. Clinico-statistical experience with a copper-potentiated IUD (Gravigard)]. Foti A; Carluccio A Minerva Ginecol; 1979 Sep; 31(9):629-38. PubMed ID: 395462 [No Abstract] [Full Text] [Related]
29. Experience with polyethylene ring: 1955-1965. 2. Sakurabayashi M Yokohama Med Bull; 1966 Dec; 17(6):209-21. PubMed ID: 5983543 [No Abstract] [Full Text] [Related]
30. Abnormal uterine bleeding due to uterine arteriovenous malformation in an early adolescent with intrauterine contraceptive device in situ. Tan I; Toh L BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38050399 [TBL] [Abstract][Full Text] [Related]
31. [The duration of contraception protection with copper intrauterine devices]. Kozuh-Novak M; Andolsek-Jeras L Jugosl Ginekol Perinatol; 1987; 27(1-2):3-5. PubMed ID: 3682889 [No Abstract] [Full Text] [Related]
32. Intrauterine contraception with the copper 7: evaluation after two years. Newton J; Elias J; McEwan J; Mann G Br Med J; 1974 Aug; 3(5928):447-50. PubMed ID: 4413973 [TBL] [Abstract][Full Text] [Related]
33. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia]. Pan J; Yu Y; Chen G Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910 [TBL] [Abstract][Full Text] [Related]
34. Complications of intrauterine contraceptive devices. Weekes LR J Natl Med Assoc; 1975 Jan; 67(1):1-10. PubMed ID: 1113333 [No Abstract] [Full Text] [Related]
38. [Prevention and treatment of IUD-induced menorrhagia with antifibrinolytic and antiprostaglandin drugs]. Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):291-4, 312. PubMed ID: 3443023 [No Abstract] [Full Text] [Related]
39. [Controlling of intrauterine devices should increase in Sweden]. Milsom I; Andersson K; Odlind V Lakartidningen; 1997 May; 94(20):1908-10. PubMed ID: 9190482 [No Abstract] [Full Text] [Related]
40. [Reasons for removal of intrauterine devices among women in general practice]. Kolding L; Majeed HG Ugeskr Laeger; 2013 Mar; 175(13):884-6. PubMed ID: 23582897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]